Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

727
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
727
Uterus and Cervix01:18

Uterus and Cervix

6.8K
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of Fetal Alcohol Spectrum Disorders in Primary Care: Use of Office Champions Model to Address Alcohol Use.

Annals of family medicine·2026
Same author

The Role of the Family Physician in Rural Maternity Care.

Clinical obstetrics and gynecology·2022
Same author

Fever of Unknown Origin in Adults.

American family physician·2022
Same author

Risk-based guidelines: Redefining management of abnormal cervical cancer screening results.

Cleveland Clinic journal of medicine·2021
Same author

Care of the College Student.

American family physician·2021
Same author

Human Papillomavirus: Screening, Testing, and Prevention.

American family physician·2021
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K

Cervical Cancer Screening.

Amy Wiser1, Jeffrey D Quinlan1

  • 1University of Iowa Carver College of Medicine, Iowa City.

American Family Physician
|March 16, 2026
PubMed
Summary
This summary is machine-generated.

Cervical cancer screening guidelines have updated, with primary HPV testing recommended as the preferred method. Screening initiation and cessation ages vary by guideline, emphasizing risk-based management for abnormal results.

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.8K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Related Experiment Videos

Last Updated: Mar 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.4K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

13.8K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Area of Science:

  • Oncology
  • Public Health
  • Gynecology

Background:

  • Cervical cancer is a significant global health concern, ranking as the fourth most common cancer in women and individuals with a cervix.
  • Population-based screening is crucial for preventing high-grade cervical precancers and cancers in asymptomatic, average-risk individuals.
  • Socioeconomic disparities contribute to underscreening in the United States.

Purpose of the Study:

  • To outline current cervical cancer screening strategies and guideline recommendations.
  • To highlight the shift towards primary human papillomavirus (HPV) testing.
  • To provide clarity on screening initiation, cessation, and management of abnormal results.

Main Methods:

  • Review of current cervical cancer screening strategies: cytology alone, cotesting, and primary HPV screening.
  • Analysis of recommendations from the American Cancer Society and the US Preventive Services Task Force (2024 draft).
  • Reference to the 2019 American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines for abnormal result management.

Main Results:

  • Primary HPV testing every 5 years is the preferred screening method from age 25 (American Cancer Society).
  • The US Preventive Services Task Force draft recommends primary HPV screening from age 30 (every 5 years) and cytology alone for ages 21-29 (every 3 years).
  • Screening cessation at 65 is recommended for individuals with adequate negative screening history and no prior high-grade lesions or cancer.

Conclusions:

  • Cervical cancer screening strategies are evolving, with a strong emphasis on primary HPV testing.
  • Guidelines differ on age recommendations, underscoring the need for personalized screening approaches.
  • Adherence to risk-based management guidelines is essential for effective patient care following abnormal screening results.